Weijie Du

2.7k total citations
47 papers, 1.7k citations indexed

About

Weijie Du is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Weijie Du has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Weijie Du's work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Weijie Du is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Weijie Du collaborates with scholars based in China, Russia and Australia. Weijie Du's co-authors include Baofeng Yang, Haihai Liang, Ye Yuan, Yanjie Lu, Chaoqian Xu, Arnold Piek, Rudolf A. de Boer, Herman H.W. Silljé, Yong Zhang and Benzhi Cai and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Construction and Building Materials.

In The Last Decade

Weijie Du

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijie Du China 26 1.2k 686 275 166 151 47 1.7k
Zhongwei Yin China 23 1.2k 1.0× 929 1.4× 432 1.6× 164 1.0× 143 0.9× 38 1.8k
Kangkai Wang China 21 1.1k 0.9× 489 0.7× 261 0.9× 232 1.4× 235 1.6× 47 1.8k
Xiaotang Ma China 26 1.2k 1.0× 806 1.2× 245 0.9× 167 1.0× 99 0.7× 51 1.8k
Yan Yao China 21 793 0.6× 411 0.6× 242 0.9× 135 0.8× 129 0.9× 77 1.6k
Yue Han China 22 843 0.7× 308 0.4× 128 0.5× 190 1.1× 151 1.0× 52 1.4k
Theresa Schmitz Germany 12 1.1k 0.9× 788 1.1× 391 1.4× 235 1.4× 84 0.6× 15 1.4k
Jiahai Shi China 21 977 0.8× 479 0.7× 252 0.9× 137 0.8× 190 1.3× 91 1.7k
Xianxian Wu China 17 832 0.7× 372 0.5× 123 0.4× 277 1.7× 211 1.4× 45 1.4k
Ji Bihl United States 24 1.3k 1.0× 777 1.1× 237 0.9× 161 1.0× 85 0.6× 47 1.8k

Countries citing papers authored by Weijie Du

Since Specialization
Citations

This map shows the geographic impact of Weijie Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Du more than expected).

Fields of papers citing papers by Weijie Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Du. The network helps show where Weijie Du may publish in the future.

Co-authorship network of co-authors of Weijie Du

This figure shows the co-authorship network connecting the top 25 collaborators of Weijie Du. A scholar is included among the top collaborators of Weijie Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijie Du. Weijie Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jie, J. Deng, Siyi Li, et al.. (2025). Explainable Machine Learning for Multicomponent Concrete: Predictive Modeling and Feature Interaction Insights. Materials. 18(19). 4456–4456. 1 indexed citations
2.
Zhang, Xi, et al.. (2025). Targeting the cGAS-STING Pathway to Modulate Immune Inflammation in Diabetes and Cardiovascular Complications: Mechanisms and Therapeutic Insights. Current Issues in Molecular Biology. 47(9). 750–750. 1 indexed citations
3.
Mei, Zhongting, Qian Liu, Guoxin Liu, et al.. (2025). Tumor Extracellular Vesicles Aggravate Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury. Advanced Science. 12(35). e17493–e17493. 1 indexed citations
4.
5.
Li, Siyi, et al.. (2025). Preparation of low-carbon precast concrete with high-content red mud and steel slag mineral admixtures. Journal of Building Engineering. 108. 112931–112931.
6.
Gareev, Ilgiz, В. Н. Павлов, Weijie Du, & Baofeng Yang. (2023). MiRNAs and Their Role in Venous Thromboembolic Complications. Diagnostics. 13(21). 3383–3383. 6 indexed citations
7.
Чупахин, Олег Н., В. Л. Русинов, Михаил В. Вараксин, et al.. (2022). Triazavirin—A Novel Effective Antiviral Drug. International Journal of Molecular Sciences. 23(23). 14537–14537. 17 indexed citations
8.
He, Mingyu, Gege Yan, Yang Wang, et al.. (2021). Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR. Journal of Cellular and Molecular Medicine. 25(11). 4962–4973. 11 indexed citations
9.
Yuan, Ye, Gege Yan, Mingyu He, et al.. (2021). ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma. Cell Death and Disease. 12(1). 60–60. 89 indexed citations
10.
Du, Weijie, Ralf Köhler, Mona Massoud, et al.. (2021). Rapid Isolation of Functional ex vivo Human Skin Tissue-Resident Memory T Lymphocytes. Frontiers in Immunology. 12. 624013–624013. 8 indexed citations
11.
Pang, Ping, Zhezhe Qu, Shuting Yu, et al.. (2021). Mettl14 Attenuates Cardiac Ischemia/Reperfusion Injury by Regulating Wnt1/β-Catenin Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 762853–762853. 29 indexed citations
12.
Yan, Gege, Lei Hong, Mingyu He, et al.. (2020). Melatonin triggers autophagic cell death by regulating RORC in Hodgkin lymphoma. Biomedicine & Pharmacotherapy. 123. 109811–109811. 14 indexed citations
13.
Li, Xin, Yu Bian, Ping Pang, et al.. (2020). Inhibition of Dectin-1 in mice ameliorates cardiac remodeling by suppressing NF-κB/NLRP3 signaling after myocardial infarction. International Immunopharmacology. 80. 106116–106116. 29 indexed citations
14.
Bian, Yu, Xin Li, Ping Pang, et al.. (2019). Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis. Acta Pharmacologica Sinica. 41(3). 319–326. 72 indexed citations
15.
Du, Weijie, Arnold Piek, Elisabeth M. Schouten, et al.. (2018). Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production. Theranostics. 8(15). 4155–4169. 67 indexed citations
16.
Jiang, Yanan, Weijie Du, Qun Chu, et al.. (2018). Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome. Cellular Physiology and Biochemistry. 45(1). 192–202. 42 indexed citations
17.
Yuan, Ye, Weijie Du, Jiaqi Liu, et al.. (2018). Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. Frontiers in Pharmacology. 9. 547–547. 75 indexed citations
18.
Du, Weijie, Haihai Liang, Xu Gao, et al.. (2016). MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis. Cellular Physiology and Biochemistry. 39(3). 827–836. 41 indexed citations
19.
Du, Weijie, Zhenwei Pan, Xu Chen, et al.. (2014). By Targeting Stat3 microRNA-17-5p Promotes Cardiomyocyte Apoptosis in Response to Ischemia Followed by Reperfusion. Cellular Physiology and Biochemistry. 34(3). 955–965. 74 indexed citations
20.
Zhang, Ying, Renjun Wang, Weijie Du, et al.. (2013). Downregulation of miR-151-5p Contributes to Increased Susceptibility to Arrhythmogenesis during Myocardial Infarction with Estrogen Deprivation. PLoS ONE. 8(9). e72985–e72985. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongwei Yin Breakdown of academic impact, for papers by Kangkai Wang Breakdown of academic impact, for papers by Xiaotang Ma Breakdown of academic impact, for papers by Yan Yao Breakdown of academic impact, for papers by Yue Han Breakdown of academic impact, for papers by Theresa Schmitz Breakdown of academic impact, for papers by Jiahai Shi Breakdown of academic impact, for papers by Xianxian Wu Breakdown of academic impact, for papers by Ji Bihl
Rankless by CCL
2026